A clinical study on Parsiaoshan in treatment of kidney stone

A Clinical Study to Evaluate the Therapeutic Safety and Efficacy of Oral Administration of Joshanda (Decoction) of Parsiaoshan (Adiantum capillus-veneris Linn.) in the Management of Hasah al-Kulya (Nephrolithiasis)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/03/032231

Enrollment

Registered

2021-03-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N200- Calculus of kidney

Interventions

Intervention1: Joshanda (Decoction) of Parsiaoshan (Adiantum capillus-veneris Linn.): 70gms of Parsiaoshan (Adiantum capillus-veneris Linn.) in the form of Decoction shall be prepared as per standard

Eligibility

Inclusion criteria

Inclusion criteria: • Clinically/Radiologically diagnosed patients of Hasah al-Kulya (Nephrolithiasis) from size 5 to 8 mm. • Patients irrespective of gender. • Patients in the age group of 20 to 60 years. • Patients who have agreed to sign the informed consent form and follow the protocol.

Exclusion criteria

Exclusion criteria: • Pregnant and Lactating Women. • Patients below and above the age of 20 and 60 years respectively. • Diabetes Mellitus. • Hydronephrosis. • Poorly controlled Hypertension. • Significant Liver or Renal dysfunction. • Cardiovascular disease. • Unwillingness or inability to fulfill the protocol. • A medical condition that in the investigatorâ??s opinion would interfere the treatment, safety, or adherence to the protocol.

Design outcomes

Primary

Measure	Time frame
relief in signs and symptoms of nephrolithiasisTimepoint: 60 days	—

Secondary

Measure	Time frame
Haematological, radiological and Biochemical assessmentTimepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Zaffar Hussain

Regional Research Institute of Unani Medicine (RRIUM)

Hussainzaffar6@gmail.com7006021996

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026